8 results
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Discontinuation of causal ... 40, F:M 9:1 • Clinical ... #comparison #table ... #rheumatology #
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Erythematosus (SLE ... ) Clinical Manifestations ... Disease, PRES Pathophysiology ... autoantibodies that will cause ... Erythematosus #SLE
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
Risk factors: Critical ... without other cause ... : 33% • Treatment ... Transfusion #Reactions #hematology ... diagnosis #comparison #table
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... accumulation of clinical ... Autoimmune diseases: SLE ... Drugs, Unknown cause ... Treatment: •
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
overlaps with RA, SLE ... salivary ducts Clinical ... Nephrogenic DI Hematologic ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Trigger Finger - Stenosing flexor tendon tenosynovitis

There is a change in the slip between the tendon
to perform active ... The diagnosis is clinical ... of non-surgical treatment ... Treatment can be ... #orthopedics #rheumatology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
histoplasmosis (>10 cases ... weeks or until clinically ... Table 5) and itraconazole ... IDSA #Prevention #Treatment ... infections #HIVAIDS #pharmacology
Tenofovir is one of the most commonly used NRTI's! The original formulation is tenofovir disoproxil fumarate
the plasma to cause ... produced in a smaller tablet ... is not enough clinical ... committee, but we will see ... #alafenamide #Pharmacology